Outcome measures: Costs during a 6-

Outcome measures: Costs during a 6-month
follow-up period in all patients and incremental
cost-effectiveness ratio per quality-adjusted life-year
(QALY) in patients with EQ-5D utility scores. Inpatient
and outpatient care was extracted from the VEGA
database. Drug costs were extracted from the Swedish
Prescribed Drug Register. A probabilistic analysis was
performed to characterise uncertainty in the costeffectiveness
model.